As an independent student newspaper and the paper of record for the city of Berkeley, the Daily Cal has been communicating important updates during this pandemic. Your support is essential to maintaining this coverage.
The Patent Trial and Appeal Board heard arguments regarding a patent dispute over the methods employed in CRISPR, a natural bacterial defense mechanism that some scientists have used to modify DNA.
Read More…
Disagreement persists between scientists at UC Berkeley and the Massachusetts Institute of Technology over the disputed patent rights to a gene-editing technology known as CRISPR-Cas9 potentially worth billions of dollars.
Read More…
